PF-AtlasClinical Trials › NCT01910818

Pilot Study of the Effect of Laser on Reversing Chronic Radiation Injury

Fractional CO2 laser treatment · Not specified

Registry ID
NCT01910818
Phase
Not specified
Status
Active, not recruiting
Drug / intervention
Fractional CO2 laser treatment
Sponsor
Massachusetts General Hospital
Start
2013-11
Enrollment
12
Locations
1

About this trial

Radiotherapy, an essential modality in cancer treatment, frequently induces a fibrotic process in the skin which can lead to increased risk of malignancy, poor wound healing, pain and limitation of movement, and permanent loss of skin appendages with hyper/hypopigmentation, decreased sweating and xerosis, posing significant cosmetic and quality of life issues. Advances in laser therapy has led to the use of fractional laser treatment (FLT) to treat fibrosis associated with in hypertrophic scars and morphea, leading to tissue repair, scar remodeling. The investigators propose a pilot clinical study to test the hypothesis that FLT can normalize the fibrotic process and induce normal scar remodeling in patients affected by chronic radiation injury. Understanding and correcting this underlying fibrotic process can help restore normal skin functions in patients affected with chronic radiation dermatitis (RD) and other debilitating fibrotic diseases in dermatology such as scleroderma, morphea, or nephrogenic systemic fibrosis.

View NCT01910818 on ClinicalTrials.gov →

Explore related

Medical disclaimer. This page summarizes public trial data for NCT01910818 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.